Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Illumina    ILMN

ILLUMINA

(ILMN)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/20/2019 05/21/2019 05/22/2019 05/23/2019 05/24/2019 Date
300.59(c) 306.47(c) 312.83(c) 308.97(c) 312.45 Last
770 501 869 534 627 544 707 895 599 871 Volume
-2.29% +1.96% +2.08% -1.23% +1.13% Change
More quotes
Financials (USD)
Sales 2019 3 770 M
EBIT 2019 1 114 M
Net income 2019 943 M
Finance 2019 2 564 M
Yield 2019 -
Sales 2020 4 309 M
EBIT 2020 1 325 M
Net income 2020 1 095 M
Finance 2020 3 409 M
Yield 2020 -
P/E ratio 2019 48,78
P/E ratio 2020 42,52
EV / Sales2019 11,4x
EV / Sales2020 9,75x
Capitalization 45 419 M
More Financials
Company
Illumina specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and... 
More about the company
Surperformance© ratings of Illumina
Trading Rating : Investor Rating :
More Ratings
Latest news on ILLUMINA
05/15ILLUMINA : Files Patent Infringement Suit Against BGI in Denmark
BU
05/07ILLUMINA : Population Health Study Goes Statewide As University Medical Center o..
PR
05/01ILLUMINA : to Webcast Upcoming Investor Conference Presentation
BU
04/25ILLUMINA : 1Q Earnings Snapshot
AQ
04/25ILLUMINA INC : Results of Operations and Financial Condition, Financial Statemen..
AQ
04/25HELIX : Expands Focus to Population Health Solutions and Appoints Illumina Veter..
PR
04/25ILLUMINA : Reports Financial Results for First Quarter of Fiscal Year 2019
BU
04/09ILLUMINA : to Announce First Quarter 2019 Financial Results on Thursday, April 2..
BU
03/29ILLUMINA : Files Patent Infringement Suit Against BGI in Germany
BU
03/26ILLUMINA : and the Lundbeck Foundation GeoGenetics Centre Collaborate to Generat..
BU
More news
Analyst Recommendations on ILLUMINA
More recommendations
Stock Trading Strategies
ILLUMINA - 2018
Underpinned by a support level
BUY
More Stock Trading Analysis
Sector news : Advanced Medical Equipment & Technology - NEC
05:53aForeign investors hope India dials back policy shocks after Modi win
RE
05/23DANAHER : FDA Alerts Hospitals, Labs, Others About Recall of Beckman Coulter Blo..
DJ
05/17EXCLUSIVE : FBI targets Johnson & Johnson, Siemens, GE, Philips in Brazil graft ..
RE
05/16Thermo Fisher to Buy Ireland API Plant From GlaxoSmithKline
DJ
05/16Philips's Netherlands Operations Now Use Only Green Energy
DJ
More sector news : Advanced Medical Equipment & Technology - NEC
Chart ILLUMINA
Duration : Period :
Illumina Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ILLUMINA
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 343 $
Spread / Average Target 11%
EPS Revisions
Managers
NameTitle
Francis A. deSouza President, Chief Executive Officer & Director
Jay T. Flatley Executive Chairman
Ostadan Omead Executive Vice President-Products & Operations
Sam A. Samad Chief Financial Officer & Senior Vice President
Mostafa Ronaghi Chief Technology Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
ILLUMINA3.01%45 419
THERMO FISHER SCIENTIFIC21.39%108 403
DANAHER CORPORATION27.75%94 238
INTUITIVE SURGICAL-1.07%54 697
BOSTON SCIENTIFIC CORPORATION6.76%52 553
SIEMENS HEALTHINEERS AG-1.19%40 922